Filtros : "Estados Unidos" "Alemanha" "IME-MAE" "CHIANN, CHANG" Removido: "SW" Limpar

Filtros



Refine with date range


  • Source: The AAPS Journal. Unidade: IME

    Subjects: BIOEQUIVALÊNCIA, FARMACOCINÉTICA, REAMOSTRAGEM BOOTSTRAP

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LOISIOS-KONSTANTINIDIS, Ioannis et al. Using physiologically based pharmacokinetic modeling to assess the risks of failing bioequivalence criteria: a tale of two ibuprofen products. The AAPS Journal, v. 22, n. Artigo 113, p. 1-9, 2020Tradução . . Disponível em: https://doi.org/10.1208/s12248-020-00495-4. Acesso em: 05 fev. 2025.
    • APA

      Loisios-Konstantinidis, I., Hens, B., Mitra, A., Kim, S., Chiann, C., & Cristofoletti, R. (2020). Using physiologically based pharmacokinetic modeling to assess the risks of failing bioequivalence criteria: a tale of two ibuprofen products. The AAPS Journal, 22( Artigo 113), 1-9. doi:10.1208/s12248-020-00495-4
    • NLM

      Loisios-Konstantinidis I, Hens B, Mitra A, Kim S, Chiann C, Cristofoletti R. Using physiologically based pharmacokinetic modeling to assess the risks of failing bioequivalence criteria: a tale of two ibuprofen products [Internet]. The AAPS Journal. 2020 ; 22( Artigo 113): 1-9.[citado 2025 fev. 05 ] Available from: https://doi.org/10.1208/s12248-020-00495-4
    • Vancouver

      Loisios-Konstantinidis I, Hens B, Mitra A, Kim S, Chiann C, Cristofoletti R. Using physiologically based pharmacokinetic modeling to assess the risks of failing bioequivalence criteria: a tale of two ibuprofen products [Internet]. The AAPS Journal. 2020 ; 22( Artigo 113): 1-9.[citado 2025 fev. 05 ] Available from: https://doi.org/10.1208/s12248-020-00495-4
  • Source: Journal of Pharmaceutical Sciences. Unidades: IME, FCF

    Subjects: BIOEQUIVALÊNCIA, SOLUBILIDADE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CRISTOFOLETTI, Rodrigo et al. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies. Journal of Pharmaceutical Sciences, v. 102, n. 9, p. 3136-3144, 2013Tradução . . Disponível em: https://doi.org/10.1002/jps.23515. Acesso em: 05 fev. 2025.
    • APA

      Cristofoletti, R., Chiann, C., Dressman, J. B., & Storpirtis, S. (2013). A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies. Journal of Pharmaceutical Sciences, 102( 9), 3136-3144. doi:10.1002/jps.23515
    • NLM

      Cristofoletti R, Chiann C, Dressman JB, Storpirtis S. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies [Internet]. Journal of Pharmaceutical Sciences. 2013 ; 102( 9): 3136-3144.[citado 2025 fev. 05 ] Available from: https://doi.org/10.1002/jps.23515
    • Vancouver

      Cristofoletti R, Chiann C, Dressman JB, Storpirtis S. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies [Internet]. Journal of Pharmaceutical Sciences. 2013 ; 102( 9): 3136-3144.[citado 2025 fev. 05 ] Available from: https://doi.org/10.1002/jps.23515

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2025